Selected bibliography
- Parkinson Study Group. Effects of tocopherol and deprenyl on the progression of disability in early Parkinson’s disease. N Engl J Med 1993; 328: 176–183.
- Shoulson I, Oakes D, Fahn S et al. Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson’s disease: a randomized placebo controlled extension of the deprenyl and tocopherol antioxidative therapy of Parkinsonism trial. Ann Neurol 2002; 51: 604–612.
- Shults CW, Oakes D, Kieburtz K et al. Effects of coenzyme Q(10) in early Parkinson’s disease: evidence of slowing of the functional decline. Arch Neurol 2002; 59: 1541–1550.
- Parkinson Study Group. A controlled, randomized, delayed- start study of vasagiline in early Parkinson disease. Arch Neurol 2004; 61: 561–566.